Ignite Creation Date:
2025-12-24 @ 9:38 PM
Ignite Modification Date:
2026-01-02 @ 10:08 AM
Study NCT ID:
NCT02482532
Status:
COMPLETED
Last Update Posted:
2022-02-04
First Post:
2015-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma
Sponsor:
Gary Doolittle
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-18
First Submit QC Date:
None
Study First Post Date:
2015-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-20
Last Update Post Date:
2022-02-04
Last Update Post Date Type:
ACTUAL